Medivation, Inc. (NASDAQ:MDVN)
CAPS Rating:
A biopharmaceutical company engaged in the acquisition, research and development of promising medical technologies.
The World's Greatest Investing Community
A biopharmaceutical company engaged in the acquisition, research and development of promising medical technologies.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
big pop and move up this year....like 300% 12 months.....think this is due a leg down while the dust settles on the Fda